Adinandra nitida tea capable of reducing high blood pressure, high blood lipid and high blood sugar and making method of adinandra nitida tea

Abstract

The invention discloses adinandra nitida tea capable of reducing high blood pressure, high blood lipid and high blood sugar. The adinandra nitida tea is characterized by being made of the following components in parts by weight: 50-60 parts of adinandra nitida tea, 23-30 parts of selenium-rich divaricate gynura roots and rhizomes, 5-10 parts of mint, 4-6 parts of lotus leaves, 10-20 parts of purple basil herbs, 10-15 parts of alpine yarrow herbs, 8-15 parts of Chinese wolfberries, 10-25 parts of plant ash, 20-40 parts of alfalfa, 7-10 parts of licorice roots, 13-15 parts of common selfheal fruit-spike, 8-10 parts of dried orange peel, 10-20 parts of jujube bark, 9-12 parts of astragalus membranaceus and 15-20 parts of lespedeza pilosa. The adinandra nitida tea capable of reducing high blood pressure, high blood lipid and high blood sugar, disclosed by the invention, has the efficacies of reducing blood lipid, reducing blood pressure and reducing blood sugar, and besides, can improve the immunity of human bodies.

Description

technical field

[0001] The invention relates to a kind of tea, in particular to a kind of Jiangsangao Shiya tea. Background technique

[0002] Three highs are the general term for hyperlipidemia, high blood pressure and high blood sugar.

[0003] Hypertension refers to higher than normal blood pressure in the circulatory system, usually refers to increased systemic arterial blood pressure, and is a common clinical syndrome. Hyperlipidemia refers to blood cholesterol or triglycerides too high or high-density lipoprotein cholesterol too low, modern medicine is called dyslipidemia. It is the main factor leading to atherosclerosis and a risk factor for the occurrence and development of cardiovascular and cerebrovascular diseases. Hyperglycemia is a higher than normal level of glucose in the body's blood. It is an independent pathological change in the body, the lesion site is in the blood, and the nature of the lesion is blood sugar metabolism disorder.

[0004] In fact, the...